REQELJA

What this means for you

This application is over — abandoned 30 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

97255833

Mark type

Stylized text

Filed

07 Feb 2022

Published for opposition

27 Dec 2022

Abandoned

30 Mar 2026

Attorney of record

Anna Kurian Shaw

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations and substances for the treatment of epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, and neurodegenerative diseases; pharmaceutical and medical preparations and substances for the treatment of pediatric epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases; medicinal infusions for the treatment of epilepsy, epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases

Owner

• Epygenix Therapeutics, Inc., Plymouth Meeting, PA, US
• Epygenix Therapeutics, Inc., Paramus, NJ, US

Prosecution history

• 30 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 30 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
• 30 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 30 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
• 01 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 31 Dec 2025 — SOU EXTENSION 5 GRANTED
• 19 Aug 2025 — SOU EXTENSION 5 FILED
• 31 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
• 12 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 11 Feb 2025 — SOU EXTENSION 4 GRANTED
• 11 Feb 2025 — SOU EXTENSION 4 FILED
• 11 Feb 2025 — SOU TEAS EXTENSION RECEIVED
• 20 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 20 Aug 2024 — SOU EXTENSION 3 GRANTED